Assessing Interest in Web/App Platforms for Early Phase Clinical Trial Recruitment

STUDY TO EVALUATE THE WILLINGNESS OF HEALTHY VOLUNTEERS, PATIENTS, DOCTORS AND PHARMACEUTICAL/BIOTECHNOLOGY INDUSTRY TO USE A PLATFORM (WEB OR APP) TO FACILITATE RECRUITMENT AND ENGAGEMENT IN EARLY PHASE CLINICAL TRIALS AND TO IMPROVE THE KNOWLEDGE OF BOTH HEALTHY VOLUNTEERS AND PATIENTS IN CLINCIAL TRIALS

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06302647

Enrollment

100

Registered

2024-03-12

Start date

2024-03-14

Completion date

2024-06-30

Last updated

2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Assessing Interest in a Platform for Early Phase Clinical Trial Recruitment

Brief summary

Study objective: To assess whether the different stakeholders (volunteers, patients, doctors and industry) involved in early phase trials would be interested in using a platform to facilitate recruitment and engagement in this type of trials. In addition, we will also evaluate the degree of awareness existing in society about clinical trials. Study subjects: General population, patient, physicians, pharmaceutical-biotechnological industry. Keywords: healthy volunteer, patient, pharma industry, patient associaiton, questionnaire, clinical trial, platform, recruitment, engagement.

Interventions

OTHERQuestionnaires

Three questionnaires have been developed to be used by subjects, pharmaceutical industry or doctors in regards to the willingness to use a platform for clinical trial recruitment

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Yes

Inclusion criteria

* Participant will be over 18 years old. * Male, female or do not want to specify. * Participants will be capable to understand spanish language. * Subjects able to communicate with the investigator and able to read and write and follow all study instructions.

Exclusion criteria

* Individuals not willing to complete the eraly phase clinical trial platform Study survey * Individuals who do not meet eligibility criteria

Design outcomes

Primary

Measure	Time frame	Description
percentage of each of the three groups that would find the platform useful	3 months	It would be deemed useful if they respond affirmatively or, in the case of a numerical scale from 1 to 5 being 1 the worse o low results and 5 the best or highest, if rate it above 4 in 80% of the questions regarding the utility of the platform.

Contacts

Primary ContactPaloma Moraga

paloma.ucicec@gmail.com914975485

Backup ContactPaloma Moraga

914975485

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026